Brand illustration · not a molecular model
01 / What is it?
What is it?
This blend combines two different peptides that can increase growth-hormone signalling in different ways. CJC-1295 works through the GHRH pathway, while Ipamorelin works through the ghrelin receptor.
The signalling chain
Follow the connection.
A simplified view of the proposed or studied pathway for CJC-1295 / Ipamorelin.
CJC-1295 / Ipamorelin
Why do people find it interesting?
Researchers are interested in how these two signals may affect natural growth-hormone pulses.
What might you notice?
There is no single effect that everyone should expect, and human research on this combination is still limited. Reported effects include deeper and more restful sleep, higher energy levels during the day and faster muscle recovery after exercise. Over time, some users also report an increase in lean muscle, less body fat, and firmer skin with improved elasticity.
What happens in your body?
Both peptides can signal the pituitary gland to release growth hormone, but they use different routes. CJC-1295 sends a GHRH-like signal, while Ipamorelin acts through the ghrelin receptor.
Keep the context
Important to know
CJC-1295 exists in versions with DAC and without DAC; these behave differently and are not interchangeable. Because this affects the GH/IGF-1 system, the guide deliberately does not give a new dosing schedule.
Read the scope & limitations ↗︎Practical context
Dose information from the guide
The guide describes a daily amount of 0.1 mg for the first two weeks, increasing to 0.15 mg during weeks 3– 4 and 0.20 mg during weeks 5–8, for a maximum total period of 8 weeks.
Look beyond the name
Similar is not the same.
This profile is general information, not medical advice or a recommendation to use a substance. Research findings and individual responses differ. Read the full scope.